These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14719396)

  • 41. Points to remember: Cardiovascular consequences of hemodialysis vascular accesses.
    Su SH
    Methodist Debakey Cardiovasc J; 2014; 10(3):202-3. PubMed ID: 25574352
    [No Abstract]   [Full Text] [Related]  

  • 42. Direct determination of blood recirculation rate in hemodialysis by a conductivity method.
    Bosc JY; LeBlanc M; Garred LJ; Marc JM; Foret M; Babinet F; Tetta C; Canaud B
    ASAIO J; 1998; 44(1):68-73. PubMed ID: 9466504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal dialysis adequacy and clinical performance of the VectorFlow hemodialysis catheter: a prospective study.
    Ross JR; Puga TA; Philbeck TE
    J Vasc Access; 2017 Nov; 18(6):492-497. PubMed ID: 28862725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subclavian catheters as temporary vascular access.
    Kong NC; Morad Z; Suleiman AB
    Singapore Med J; 1989 Jun; 30(3):261-2. PubMed ID: 2588017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodialysis catheter placement and management.
    Trerotola SO
    Radiology; 2000 Jun; 215(3):651-8. PubMed ID: 10831680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Placement of dual lumen non-cuffed dialysis catheter into persistent left superior vena cava.
    Sriramnaveen P; Krishna Kishore C; Sainaresh VV; Sivaramakrishna G; Vijayalakshmi Devi B; Lakshmi AY; Sivakuma V
    Clin Nephrol; 2010 Jan; 73(1):81-2. PubMed ID: 20040358
    [No Abstract]   [Full Text] [Related]  

  • 47. Six cases of retained central venous haemodialysis access catheters.
    Hassan A; Khalifa M; Al-Akraa M; Lord R; Davenport A
    Nephrol Dial Transplant; 2006 Jul; 21(7):2005-8. PubMed ID: 16632560
    [No Abstract]   [Full Text] [Related]  

  • 48. A circuitous detour.
    Vachharajani TJ; Vachharajani V
    Kidney Int; 2011 Jun; 79(12):1383. PubMed ID: 21625265
    [No Abstract]   [Full Text] [Related]  

  • 49. Retained central venous haemodialysis access catheters.
    Liu T; Hanna N; Summers D
    Nephrol Dial Transplant; 2007 Mar; 22(3):960-1; author reply 961. PubMed ID: 17192277
    [No Abstract]   [Full Text] [Related]  

  • 50. Right atrial bypass grafting for central venous obstruction associated with dialysis access: another treatment option.
    El-Sabrout RA; Duncan JM
    J Vasc Surg; 1999 Mar; 29(3):472-8. PubMed ID: 10069911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Management of complications of hemodialysis vascular accesses].
    Chanis G
    Rev Med Panama; 2000; 25():11-8. PubMed ID: 15881742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vascular access for hemodialysis under difficult conditions. Our experience].
    Montalcini G; Biamino E; Caligaris F; Ferrero S; Imarisio P; Bongiorno P
    Minerva Urol Nefrol; 1998 Mar; 50(1):35-8. PubMed ID: 9578655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Arteriovenous vascular access flow measurement: accuracy and clinical implications.
    Krivitski N; Schneditz D
    Contrib Nephrol; 2004; 142():269-84. PubMed ID: 14719399
    [No Abstract]   [Full Text] [Related]  

  • 54. Necklace fistula for complicated dialysis access patients.
    Sirlak M; Eryilmaz S; Cakici M; Inan B; Kaya B; Ozyurda U
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):64-5. PubMed ID: 19196579
    [No Abstract]   [Full Text] [Related]  

  • 55. Translumbar inferior vena cava catheter: An unconventional dialysis access.
    Foley AM
    J Vasc Nurs; 2015 Jun; 33(2):79-80. PubMed ID: 26025152
    [No Abstract]   [Full Text] [Related]  

  • 56. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
    Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
    [No Abstract]   [Full Text] [Related]  

  • 57. Four percent trisodium citrate as an alternative anticoagulant for maintaining patency of central venous hemodialysis catheters: case report and discussion.
    Michaud D; Komant T; Pfefferle P
    Am J Crit Care; 2001 Sep; 10(5):351-4. PubMed ID: 11548568
    [No Abstract]   [Full Text] [Related]  

  • 58. Effective flow performances and dialysis doses delivered with permanent catheters: a 24-month comparative study of permanent catheters versus arterio-venous vascular accesses.
    Canaud B; Leray-Moragues H; Kerkeni N; Bosc JY; Martin K
    Nephrol Dial Transplant; 2002 Jul; 17(7):1286-92. PubMed ID: 12105254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical alternatives to central venous catheters in chronic renal replacement therapy.
    Mickley V
    Nephrol Dial Transplant; 2003 Jun; 18(6):1045-51. PubMed ID: 12748332
    [No Abstract]   [Full Text] [Related]  

  • 60. Indwelling silicone femoral catheters: experience of three haemodialysis centres.
    Montagnac R; Bernard C; Guillaumie J; Hanhart P; Clavel P; Yazji J; Martinez LM; Schillinger F
    Nephrol Dial Transplant; 1997 Apr; 12(4):772-5. PubMed ID: 9141010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.